|
|
|
Volumn 22, Issue 1 A, 2002, Pages 27-32
|
|
Evidence of a field effect associated with mammary cancer chemoprevention by methylseleninic acid
a
a
|
|
Author keywords
cDNA microarray analysis; Mammary premalignant lesions; Methylseleninic acid; Molecular biomarkers
|
|
Indexed keywords
BIOLOGICAL MARKER;
CYCLIN A;
CYCLIN D1;
METHYLSELENINIC ACID;
PROTEIN BAX;
PROTEIN BCL 2;
PROTEIN P21;
PROTEIN P27;
SELENIUM DERIVATIVE;
SELENOAMINO ACID;
UNCLASSIFIED DRUG;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANIMAL TISSUE;
APOPTOSIS;
ARTICLE;
BREAST CANCER;
CANCER PREVENTION;
CELL CYCLE;
CELL DIFFERENTIATION;
CELL GROWTH;
CHEMOPROPHYLAXIS;
CONTROLLED STUDY;
DNA MICROARRAY;
DRUG EFFECT;
EPITHELIUM CELL;
FEMALE;
GENE EXPRESSION PROFILING;
NONHUMAN;
PRIORITY JOURNAL;
RAT;
RNA ISOLATION;
ANIMALS;
ANTICARCINOGENIC AGENTS;
CELL CYCLE PROTEINS;
FEMALE;
GENE EXPRESSION;
GENE EXPRESSION PROFILING;
MAMMARY GLANDS, ANIMAL;
MAMMARY NEOPLASMS, EXPERIMENTAL;
OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS;
ORGANOSELENIUM COMPOUNDS;
PRECANCEROUS CONDITIONS;
RATS;
RATS, SPRAGUE-DAWLEY;
TUMOR MARKERS, BIOLOGICAL;
|
|
EID: 0036244543
PISSN: 02507005
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (17)
|
|
References (15)
|
